Association between acid suppressive therapy and spontaneous bacterial peritonitis in cirrhotic patients with ascites

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 5, 2011, Pages 616-620

  Choi, Eun Jung ^a   Lee, Heon Ju ^a   Kim, Kyeong Ok ^a   Lee, Si Hyung ^a   Eun, Jong Ryul ^a   Jang, Byung Ik ^a   Kim, Tae Nyeun ^a  

^a Yeungnam University College of Medicine   (South Korea)

Author keywords

Acid suppressive therapy; cirrhosis; H2 receptor antagonist; proton pump inhibitor; spontaneous bacterial peritonitis

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; ASCITES; ASCITES FLUID; BACTERIAL PERITONITIS; BACTERIUM CULTURE; CHILD PUGH CLASS C; FEMALE; HUMAN; HUMAN CELL; INFECTION RISK; LEUKOCYTE; LEUKOCYTE COUNT; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; PARACENTESIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; SCORING SYSTEM; SPONTANEOUS BACTERIAL PERITONITIS;

ADULT; AGED; ASCITES; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HISTAMINE H2 ANTAGONISTS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PERITONITIS; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79954503170     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2011.551891     Document Type: Article

References (20)

1. Rimola A, García-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, Inadomi JM. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 2000;32:142-53. (Pubitemid 30039459)
2. Cuarner C, Runyon BA, Young S, Heck M, Sheikh MY. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 1997;26:1372-8. (Pubitemid 27346652)
3. Lee JM, Han KH, Ahn SH. Ascites and spontaneous bacterial peritonitis: an Asian perspective. J Gastroenterol Hepatol 2009;24:1494-503.
4. Sánchez E, Such J, Chiva MT, Soriano G, Llovet T, Mercè J, et al. Development of an experimental model of induced bacterial peritonitis in cirrhotic rats with or without ascites. Am J Gastroenterol 2007;102:1230-6. (Pubitemid 46802027)
5. Naunton M, Peterson GM, Bleasel MD. Overuse of proton pump inhibitors. J Clin Pharm Ther 2000;25:333-40. (Pubitemid 32002877)
6. Martinsen TC, Bergh K, Waldum HL. Gastric juice: a barrier against infectious disease. Basic Clin Pharmacol Toxicol 2005;96:94-102. (Pubitemid 40320612)
7. Laheij R, Sturkenboom MC, Hassing R, Dieleman J, Stricker BH, Jansen SB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004; 292:1955-60. (Pubitemid 39411203)
8. Prod'hom G, Leuenberger P, Koerfer J, Blum A, Chiolero R, Schaller MD, et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial. Ann Intern Med 1994;120:653-62. (Pubitemid 24106177)
9. Howell MD, Novack V, Grgurich P, Soulliard D, Novack L, Pencina M, Talmor D. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 2010;170:784-90.
10. Dial S, Delaney JAC, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of communityacquired Clostridium difficile-associated disease. JAMA 2005;294:2989-95. (Pubitemid 41817660)
11. Parkman HP, Urbain JL, Knight LC, Brown KL, Trate DM, Miller MA, et al. Effect of gastric acid suppressants on human gastric motility. Gut 1998;42:243-50. (Pubitemid 28212180)
12. Zedtwitz-Liebenstein K, Wenisch C, Patruta S, Parschalk B, Daxbock F, Graninger W. Omeprazole treatment diminished intra- and extracellular neutrophil reactive oxygen production and bactericidal activity. Crit Care Med 2002;30: 1118-22. (Pubitemid 34508037)
13. Campbell MS, Obstein K, Reddy KR, Yang YX. Association between proton pump inhibitor use and spontaneous bacterial peritonitis. Dig Dis Sci 2008;53:394-8. (Pubitemid 351170039)
14. Bajaj JS, Zadvornova Y, Heuman DM, Hafeezullah M, Hoffmann RG, Sanyal AJ, Saeian K. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. Am J Gastroenterol 2009; 104:1130-4.
15. Bauer TM, Steinbrückner B, Brinkmann FE, Ditzen AK, Schwacha H, Aponte JJ, et al. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol 2001;96:2962-7. (Pubitemid 32959540)
16. Koulaouzidis A, Bhat S, Karagiannidis A, Tan WC, Linaker BD. Spontaneous bacterial peritonitis. Postgrad Med J 2007;83:379-83. (Pubitemid 46960823)
17. Thorens J, Froehlich F, Schwizer W, Saraga E, Bille J, Gyr K, et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine. Gut 1996; 39: 54-9.
18. Takahashi Y, Amano Y, Yuki T, Ose T, Miyake T, Kushiyama Y, et al. Influence of acid suppressants on gastric emptying: Cross-over analysis in healthy volunteers. J Gastroenterol Hepatol 2006;21:1664-8. (Pubitemid 44410875)
19. Kalaitzakis E, Björnsson E. Inadequate use of proton-pump inhibitors in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2008;20:512-18. (Pubitemid 351667891)
20. Runyon BA, Cannwati HN, Akriviatis EA. Optimization of ascetic fluid culture technique. Gastroenterology 1998;95: 1351-5.